Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $363.50 +0.83%
Revenue Growth %: -0.5%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
ORPB, PBCO, SICP, More
Revenue Growth %: -0.5%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Oregon Pacific Bancorp (ORPB) Tops Q3 EPS by 38c
- National Bankshares Inc (NKSH) Misses Q3 EPS by 12c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
